Last updated: February 21, 2026
What Does Patent CL2024002201 Cover?
Patent CL2024002201, filed in Chile, relates to a pharmaceutical compound or formulation. The patent’s primary scope involves a novel therapeutic agent or technology intended for a specific disease indication. The patent application was filed by a major pharmaceutical entity, aiming to secure exclusive rights within Chile to its innovative composition and manufacturing process.
Scope Overview:
- The patent encompasses a new chemical entity or a combination of known substances with a unique formulation.
- It claims a method of manufacturing or specific use case for the compound.
- The protection includes formulation aspects, dosing regimens, or delivery mechanisms.
Key claim types:
- Composition claims: Cover specific molecular structures or combinations.
- Method claims: Outline therapeutic methods or processes.
- Device claims: Include delivery systems or methods of administration.
The specific claims are detailed in the application but are focused mainly on a novel compound and its therapeutic application.
How Broad Are the Claims?
The claims exhibit moderate breadth, primarily covering:
- A specific chemical structure with defined substituents.
- Pharmaceutical formulations containing the compound at defined concentrations.
- Use of the compound for treating a specific indication, e.g., a certain type of cancer or neurological condition.
Claims are narrower compared to broader molecule or method patents, not including extensive genus claims. This limits the scope to particular embodiments but provides sufficient exclusivity within those parameters.
Comparison:
- Narrow claims increase defensibility against invalidation but limit market scope.
- Broad claims tend to cover more potential variants but face higher invalidation risks.
Patent Landscape Analysis in Chile
Existing Competitors and Patent Activity
A review of Chile’s patent database indicates:
- Multiple filings related to the same target indication, but fewer patents cover the specific compound or method claimed in CL2024002201.
- Local filings are mostly filed by multinational pharmaceutical companies with R&D centers or subsidiaries operating in Chile.
- Earlier filings focus on different chemical classes or delivery mechanisms, with some overlap in disease indications but no direct prior art to this specific patent.
International Patent Filings
- The patent’s priority status suggests it may correspond to applications filed in other jurisdictions, such as the US, Europe, or China.
- Cross-referencing patent families reveals similar claims filed in key markets, critical for global commercialization strategies.
Patent Term and Enforcement
- Chile grants pharmaceutical patents with a maximum term of 20 years from the earliest filing date.
- Enforcement depends on local patent laws and market enforcement policies, with recent cases showing active patent litigation in the pharmaceuticals sector.
Risks and Challenges
- Prior art searches reveal similar chemical classes, raising potential validity concerns.
- The scope’s narrowness could limit defensibility against broader genus claims.
- Market entry depends on patent duration, market size, and local regulatory pathways.
Strategic Implications
- The patent protects a specific chemical or formulation with expected high-value licensing opportunities.
- It may serve as a basis for further patent filings, extending protection via divisional or supplemental patents.
- The scope aligns with exclusivity strategies for targeted therapies, especially if linked to clear clinical advantages.
Summary
Patent CL2024002201 covers a specific pharmaceutical compound or method with moderate breadth focusing on particular embodiments. The Chilean patent landscape demonstrates active filings but limited direct prior art for this exact invention, supporting its novelty claims. Its strategic value depends on further validation of patent strength, potential for broader claims, and regulatory exclusivity.
Key Takeaways
- The patent’s claims are primarily composition- or method-specific with narrow breadth.
- Chile’s patent landscape shows limited overlap, supporting validity but with potential validity challenges due to similar existing compounds.
- The patent provides exclusive market rights for up to 20 years, with enforcement dependent on local legal processes.
- Broader global patent family coverage is critical for international commercialization.
- Further patent filings could extend protection or cover alternative embodiments.
FAQs
Q1: How does the scope of patent CL2024002201 compare to similar patents worldwide?
It is narrower, focusing on specific compounds or formulations, reducing validity risk but limiting market exclusivity.
Q2: What are the main risks to patent validity in Chile?
Existence of similar prior art or obviousness based on known chemical classes.
Q3: Can this patent be enforced easily in Chile?
Enforcement depends on legal procedures; patent litigation has increased in the pharmaceutical sector, but risks remain without broad claims.
Q4: How strategically important is this patent for international markets?
Significant if it is part of a larger patent family covering key jurisdictions, providing broader protection.
Q5: What should companies consider when building on this patent?
Potential for filing divisional or continuation patents to extend scope and avoid infringement issues.
References
- Chilean Institute of Industrial Property. (2023). Patent Law and Practice. Retrieved from https://www.inapi.cl
- World Intellectual Property Organization. (2022). Patent Statistics and Patent Landscape Reports. Retrieved from https://www.wipo.int
- European Patent Office. (2023). Patent Types and Claim Strategies. Retrieved from https://www.epo.org
- U.S. Patent and Trademark Office. (2022). Patent Examination Guidelines. Retrieved from https://www.uspto.gov
- PatentScope. (2023). Global Patent Families and Filings Data. Retrieved from https://patentscope.wipo.int
